Skip to main content
Clinical Trials/NL-OMON53733
NL-OMON53733
Recruiting
Not Applicable

Randomized controlled clinical trial on the application of Heli-FX EndoAnchors in conjunction with the Endurant II/IIs endograft in infrarenal aortic aneurysms with a wide infrarenal neck - HERCULES Trial

Rijnstate Ziekenhuis0 sites28 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Rijnstate Ziekenhuis
Enrollment
28
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Rijnstate Ziekenhuis

Eligibility Criteria

Inclusion Criteria

  • Age 18 years or older
  • Provided written informed consent
  • Clinical necessity for treatment of the AAA, according to the current
  • guidelines in the geographies participating
  • Elective repair
  • Eligible anatomy for treatment with the Endurant II/IIs endograft and Heli\-FX
  • EndoAnchors according to the IFU of both devices
  • Infrarenal neck diameter \>\= 28 mm and \<\=32 mm
  • Proximal neck length \>\=10mm

Exclusion Criteria

  • Anatomy outside the IFU of the Endurant II/IIs endograft and/or Heli\-FX
  • EndoAnchors
  • Planned use of AUI main body device
  • Patient is participating in another clinical study, potentially conflicting
  • with the outcomes of the current study.
  • Patient with eGFR \< 30 ml/min/1\.73m2 before the intervention
  • Patient\*s life expectancy \<2 years as judged by the investigator
  • Patient has a psychiatric or other condition that may interfere with the study
  • Patient has a known allergy to any device component
  • Patients with a systemic infection who may be at increased risk of

Outcomes

Primary Outcomes

Not specified

Similar Trials